VIRX

Viracta Therapeutics, Inc. Common Stock

Delisted

VIRX was delisted on the 3rd of February, 2025.

42 hedge funds and large institutions have $5.61M invested in Viracta Therapeutics, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 7 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
42
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1K
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$96.1K
2 +$65.2K
3 +$23.6K
4
Squarepoint
Squarepoint
New York
+$20.6K
5
Renaissance Technologies
Renaissance Technologies
New York
+$17.5K
Name Holding Trade Value Shares
Change
Change in
Stake
26
$6.7K
27
$6K
28
$5.86K
29
$4.6K
30
$4.28K
31
$4.15K
32
$2.11K
33
$2K
34
$1.71K
35
$411
36
$217
37
$114
38
$8
39
$5
40
$3
41
$2
42
$1
43
44
45
46
47